Alito temporarily restores FDA rule allowing abortion pill to be sent by mail

Justice Samuel Alito temporarily halted an appellate court order that blocked a rule by the Food and Drug Administration (FDA) allowing the abortion pill mifepristone to be prescribed online and sent through the mail. This decision provides temporary relief to Danco Laboratories and GenBioPro, the companies behind mifepristone and its generic version, until May 11. The Supreme Court now has more time to consider the drug companies’ requests to overturn the appellate court’s decision while the case continues. The issue of mifepristone’s availability has reached the Supreme Court again after anti-abortion groups challenged the FDA’s approval and relaxed rules for the drug. In 2024, the Supreme Court dismissed a similar challenge, ruling that the plaintiffs lacked the legal right to sue. The FDA had eased restrictions on mifepristone, allowing it to be prescribed via telehealth and mailed, especially during the COVID-19 pandemic. However, Louisiana officials challenged this, leading to a temporary block by the U.S. Court of Appeals for the 5th Circuit. QUESTION: How might the Supreme Court’s decision on mifepristone’s availability impact future access to medication through telehealth services?